Abstract
This synopsis is intended to provide policymakers with a brief summary of the latest forecasts for global need, demand, and procurement of malaria diagnostics and treatments, and the implications of these forecasts for health and development policy. These forecasts have been produced by a consortium including the Clinton Health Access Initiative, Inc. (CHAI), IMS Health (IMS), and the University of California, San Francisco (UCSF). This consortium is funded by UNITAID and operates under the guidance of a Steering Committee consisting of representatives from The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), Medicines for Malaria Venture (MMV), UNITAID, the US President’s Malaria Initiative (PMI), and the World Health Organization (WHO).